Q3 2024 saw net sales drop 32% year-over-year to €17.2M, with a -€16.3M EBIT due to a €13.2M impairment. Cash constraints led to covenant breaches and ongoing lender negotiations, while cost reductions and a strategic shift aim to restore stability.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.